NewsBenzingaAlaunos Therapeutics周四提交了专利申请《新抗原反应T细胞受体的鉴定》 Alaunos Therapeutics周四提交了专利申请《新抗原反应T细胞受体的鉴定》 Benzinga 2026.09.18 09:12 (GMT+0) Open on Benzinga Other news UBS Maintains Buy on CDW, Raises Price Target to $195 UBS Maintains Buy on Addus HomeCare, Raises Price Target to $160 UBS Maintains Neutral on Qualcomm, Lowers Price Target to $180 UBS Maintains Neutral on HubSpot, Lowers Price Target to $240 UBS Maintains Buy on Edwards Lifesciences, Raises Price Target to $118 UBS Maintains Buy on Amplitude, Raises Price Target to $22
